NEUROLOGY 2004

1de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. New Engl J Med 2002; 347(20): 1549-56.

2 Heyderman RS HP Lambert , O’SulliVan I Early management of suspected bacterial meningitis and meningococcal septicaemia in adults. J Infect 2003; 46(2):75-7.

3The International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms - risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339(24): 1725-33.

4Wardlaw JM,White PM. The detection and management of unruptured intracranial aneurysms. Brain 2000; 123(2):205-21.

5 Molyneux A R Kerr Stratton I International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2,143 patients with ruptured intracranial aneurysms:a randomised trial. Lancet 2002; 360(9342): 1267-74.

6 Confavreux C S Vukusic Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126(4):770-82.

7 Lublin FDM MP Baier Cutter GP. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003; 61(11): 1528-32.

8 Liu C Blumhardt LD. Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts. J Neurol Neurosurg Psychiatry 2000; 68(4):450-7.

9 Confavreux C S Vukusic Moreau T Relapses and progression of disability in multiple sclerosis. New Engl J Med 2000; 343(20): 1430-8.

10Coles AJ,Wing MG, Molyneux P Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999; 46:296-304.

11 Lefebvre S L Burglen Reboullet S Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80(1): 155-65.